Biotech & Pharma

Single-Cell RNA Sequencing Reveals Gene Activity Changes in Crohn's Disease

30 sec read8 views0 listens

Researchers from the Wellcome Sanger Institute and partners have mapped gene activity changes across over a million gut cells in Crohn’s disease patients, identifying new molecular signatures of immune activity. This detailed cellular study provides a powerful tool for researchers to understand inflammation mechanisms and develop targeted therapies, accelerating drug discovery for Crohn’s disease.

This comprehensive dataset will help identify novel therapeutic targets and improve treatment outcomes for inflammatory bowel diseases like Crohn's.

Read the full article at Genetic Engineering News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

ZoBio Introduces DNA-Encoded Library Service for Exploratory Drug Discovery Programs

ZoBio has launched a comprehensive DNA-Encoded Library (DEL) discovery service to aid in the identification of drug targets that are difficult or novel. This integrated platform combines multiple techniques, including protein production, biophysical ...

Ali Nemati

Legal & Policy4 days ago30 sec read

'Someone Stop Them From Doing This Again': Biglaw Recruiting Is Making 1Ls Miserable

A recent survey reveals that 67% of first-year law students find accelerated Biglaw recruiting timelines detrimental to their academic development and mental well-being. Human resources and tech recruiters should consider how these hastened schedules...

Ali Nemati

Biotech & Pharma5 days ago31 sec read

Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins

Physicists at UC Berkeley have developed a laser-driven phase plate (LPP) that significantly enhances the resolution of cryo-electron microscopy (cryo-EM) for small proteins, overcoming a major limitation of the technique. This advancement allows for...

Ali Nemati

Biotech & PharmaJun 531 sec read

A Billion-Dollar Deal, Trial Trouble, Biohub Updates, and Vaccine Research News

Eli Lilly has signed a $1.9 billion agreement with Ascidian Therapeutics to advance a pipeline of RNA exon editors specifically targeting inherited kidney diseases. This massive investment highlights a growing industry focus on high-precision genetic...

Ali Nemati

Biotech & PharmaJun 231 sec read

Low-Cost, Portable Biotech Tools Improve Access to Bioresearch and Diagnostics

A research team at the University of Toronto has successfully demonstrated a suite of portable biotech tools that utilize freeze-dried reagents and cell-free protein synthesis to produce high-value biological materials. These low-cost systems enable ...

Ali Nemati

Single-Cell RNA Sequencing Reveals Gene Activity Changes in Crohn's Disease

Related Articles

ZoBio Introduces DNA-Encoded Library Service for Exploratory Drug Discovery Programs

'Someone Stop Them From Doing This Again': Biglaw Recruiting Is Making 1Ls Miserable

Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins

A Billion-Dollar Deal, Trial Trouble, Biohub Updates, and Vaccine Research News

Low-Cost, Portable Biotech Tools Improve Access to Bioresearch and Diagnostics